Cargando…

Gadolinium-labelled iron/iron oxide core/shell nanoparticles as T(1)–T(2) contrast agent for magnetic resonance imaging

Magnetic resonance imaging (MRI) is indispensable and powerful in modern clinical diagnosis and has some advantages such as non-invasiveness and high penetration depth. Furthermore, dual T(1)–T(2) MR imaging has attracted crucial interest as it can decrease the risk of pseudo-positive signals in dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Kaili, An, Lu, Tian, Qiwei, Lin, Jiaomin, Yang, Shiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2018
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083088/ https://www.ncbi.nlm.nih.gov/pubmed/35541075 http://dx.doi.org/10.1039/c8ra04530e

Ejemplares similares

Macromolecules with Different Charges, Lengths, and Coordination Groups for the Coprecipitation Synthesis of Magnetic Iron Oxide Nanoparticles as T(1) MRI Contrast Agents
por: Tao, Cheng, et al.
Publicado: (2019)

T(1)-Weight Magnetic Resonance Imaging Performances of Iron Oxide Nanoparticles Modified with a Natural Protein Macromolecule and an Artificial Macromolecule
por: Tao, Cheng, et al.
Publicado: (2019)

Cubic Iron Core–Shell Nanoparticles Functionalized to Obtain High-Performance MRI Contrast Agents
por: Volokhova, Maria, et al.
Publicado: (2022)

Concurrent Dual Contrast for Cellular Magnetic Resonance Imaging Using Gadolinium Oxide and Iron Oxide Nanoparticles
por: Loai, Yasir, et al.
Publicado: (2012)

Synthesis route and three different core-shell impacts on magnetic characterization of gadolinium oxide-based nanoparticles as new contrast agents for molecular magnetic resonance imaging
por: Azizian, Gholamreza, et al.
Publicado: (2012)

Analytical Interference in Serum Iron Determination Reveals Iron Versus Gadolinium Transmetallation With Linear Gadolinium-Based Contrast Agents
por: Fretellier, Nathalie, et al.
Publicado: (2014)

Magnetic properties of biofunctionalized iron oxide nanoparticles as magnetic resonance imaging contrast agents
por: Gervits, Natalia E, et al.
Publicado: (2019)

Magnetic resonance and ultrasound contrast imaging of polymer-shelled microbubbles loaded with iron oxide nanoparticles
por: Sciallero, Claudia, et al.
Publicado: (2016)

Carbon-coated iron oxide nanoparticles as contrast agents in magnetic resonance imaging
por: Bae, Hongsub, et al.
Publicado: (2012)

New Dual Mode Gadolinium Nanoparticle Contrast Agent for Magnetic Resonance Imaging
por: Ghaghada, Ketan B., et al.
Publicado: (2009)

Label-Free Iron Oxide Nanoparticles as Multimodal Contrast Agents in Cells Using Multi-Photon and Magnetic Resonance Imaging
por: Reynders, Hendrik, et al.
Publicado: (2021)

Controlling Magnetization Reversal and Hyperthermia Efficiency in Core–Shell Iron–Iron Oxide Magnetic Nanoparticles by Tuning the Interphase Coupling
por: Simeonidis, K., et al.
Publicado: (2020)

Functionalized magnetic iron oxide/alginate core-shell nanoparticles for targeting hyperthermia
por: Liao, Shih-Hsiang, et al.
Publicado: (2015)

Design and Synthesis of Gold-Gadolinium-Core-Shell Nanoparticles as Contrast Agent: a Smart Way to Future Nanomaterials for Nanomedicine Applications
por: Aouidat, Fatima, et al.
Publicado: (2019)

Formation of gadolinium–ferritin from clinical magnetic resonance contrast agents
por: Neburkova, Jitka, et al.
Publicado: (2020)

A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: a mouse study
por: Balivada, Sivasai, et al.
Publicado: (2010)

The Effects of a Varied Gold Shell Thickness on Iron Oxide Nanoparticle Cores in Magnetic Manipulation, T(1) and T(2) MRI Contrasting, and Magnetic Hyperthermia
por: Brennan, Grace, et al.
Publicado: (2020)

Design and Synthesis of Gold-Gadolinium-Core-Shell Nanoparticles as Contrast Agent: a Smart Way to Future Nanomaterials for Nanomedicine Applications [Retraction]
Publicado: (2022)

Smart nanomedicine agents for cancer, triggered by pH, glutathione, H(2)O(2), or H(2)S
por: Li, Yaping, et al.
Publicado: (2019)

Folic acid-targeted iron oxide nanoparticles as contrast agents for magnetic resonance imaging of human ovarian cancer
por: Zhang, He, et al.
Publicado: (2016)

Iron phosphide nanoparticles as a pH-responsive T(1) contrast agent for magnetic resonance tumor imaging
por: Qiu, Yuan, et al.
Publicado: (2019)

Iron oxide nanoparticles as positive T(1) contrast agents for low-field magnetic resonance imaging at 64 mT
por: Oberdick, Samuel D., et al.
Publicado: (2023)

T(1)–T(2) Dual-modal MRI contrast agents based on superparamagnetic iron oxide nanoparticles with surface attached gadolinium complexes
por: Szpak, Agnieszka, et al.
Publicado: (2014)

Ellagic acid-Fe@BSA nanoparticles for endogenous H(2)S accelerated Fe(III)/Fe(II) conversion and photothermal synergistically enhanced chemodynamic therapy
por: Tian, Qingqing, et al.
Publicado: (2020)

Magnetic core–shell nanowires as MRI contrast agents for cell tracking
por: Martínez-Banderas, Aldo Isaac, et al.
Publicado: (2020)

Engineered Protein-Driven Synthesis of Tunable Iron Oxide Nanoparticles as T1 and T2 Magnetic Resonance Imaging Contrast Agents
por: Aires, Antonio, et al.
Publicado: (2022)

Gadolinium retention and clearance after administration of macrocyclic magnetic resonance contrast agents to rats
por: Bussi, Simona, et al.
Publicado: (2019)

BSA-assisted synthesis of ultrasmall gallic acid–Fe(III) coordination polymer nanoparticles for cancer theranostics
por: Mu, Xueling, et al.
Publicado: (2017)

Gadolinium-hyaluronic acid nanoparticles as an efficient and safe magnetic resonance imaging contrast agent for articular cartilage injury detection
por: Lu, Rong, et al.
Publicado: (2020)

Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imaging
por: Hachani, Roxanne, et al.
Publicado: (2017)

Efficient labeling in vitro with non-ionic gadolinium magnetic resonance imaging contrast agent and fluorescent transfection agent in bone marrow stromal cells of neonatal rats
por: LI, YING-QIN, et al.
Publicado: (2015)

The anticancer properties of iron core–gold shell nanoparticles in colorectal cancer cells
por: Wu, Ya-Na, et al.
Publicado: (2013)

Synthesis and Magneto-Thermal Actuation of Iron Oxide Core–PNIPAM Shell Nanoparticles
por: Kurzhals, Steffen, et al.
Publicado: (2015)

Automated droplet reactor for the synthesis of iron oxide/gold core-shell nanoparticles
por: Ahrberg, Christian D., et al.
Publicado: (2020)

Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement
por: Swanson, Scott D, et al.
Publicado: (2008)

Development and Characterization of an Antibody-Labeled Super-Paramagnetic Iron Oxide Contrast Agent Targeting Prostate Cancer Cells for Magnetic Resonance Imaging
por: Bates, David, et al.
Publicado: (2014)

Iron Oxide@Mesoporous Silica Core-Shell Nanoparticles as Multimodal Platforms for Magnetic Resonance Imaging, Magnetic Hyperthermia, Near-Infrared Light Photothermia, and Drug Delivery
por: Adam, Alexandre, et al.
Publicado: (2023)

Comparing the signal enhancement of a gadolinium based and an iron-oxide based contrast agent in low-field MRI
por: van Zandwijk, Jordy K., et al.
Publicado: (2021)

In situ self-assembly of amphiphilic dextran micelles and superparamagnetic iron oxide nanoparticle-loading as magnetic resonance imaging contrast agents
por: Jiang, Linrui, et al.
Publicado: (2022)

Superparamagnetic Iron Oxide Nanoparticles as MRI contrast agents for Non-invasive Stem Cell Labeling and Tracking
por: Li, Li, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_p25ic1gqtcm238n98bqr2ng2ui